Loading clinical trials...
Loading clinical trials...
A Randomized, Open-Label, Comparative Evaluation of the Safety and Efficacy of Sirolimus Versus Cyclosporine When Combined in a Regimen Containing Basiliximab, Mycophenolate Mofetil, and Corticosteroids in Primary De Novo Renal Allograft Recipients
Conditions
Interventions
sirolimus
Locations
82
United States
San Diego, California, United States
San Francisco, California, United States
Denver, Colorado, United States
New Haven, Connecticut, United States
Gainesville, Florida, United States
Tampa, Florida, United States
Start Date
June 1, 2005
Primary Completion Date
August 1, 2006
Completion Date
August 1, 2006
Last Updated
February 8, 2013
NCT05702398
NCT07415421
NCT07006532
NCT07333495
NCT04542733
NCT06958796
Lead Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions